Why is Jagsonpal Pharma falling/rising?

As of 11-Aug, Jagsonpal Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 250.50, reflecting a decrease of Rs 5.45 or 2.13%. The stock has underperformed its sector by 3.04% today and has been on a downward trend for the last two days, with a total decline of 6.95% during this period. Additionally, the stock touched an intraday low of Rs 247, indicating a significant drop. Despite a strong long-term performance with a 72.05% return over the past year and consistent positive results over the last five quarters, the recent fall in investor participation, as evidenced by a 26.15% drop in delivery volume, may be contributing to the current price movement.
In the broader market context, the stock's short-term performance has been notably weaker compared to the benchmark, with a 1-week return of -7.80% against the Sensex's -0.51%. This underperformance in the short term contrasts with its positive long-term growth metrics, such as a healthy operating profit growth rate of 42.31% and a low debt-to-equity ratio. While the company has shown resilience and strong fundamentals, the recent decline in stock price may reflect broader market sentiments or profit-taking by investors after a substantial rise in previous periods.